MedPath

CHIP-MI: Investigating the role of clonal haematopoiesis of indeterminate potential (CHIP) in the inflammatory system after myocardial infarction (MI).

Not Applicable
Conditions
Myocardial Infarction
Cardiovascular - Coronary heart disease
Registration Number
ACTRN12624001041549
Lead Sponsor
Monash University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

1.Age 65 years or older
2.Able to provide written, voluntary and informed consent.
3.Willing to complete all study procedures during the visit.
4.Able to undergo collection of blood specimens.
5.Diagnosis of myocardial infarction 3-12 months prior to enrolment date.

Exclusion Criteria

1.Unable to complete all study procedures during the visit.
2.Not appropriate to have blood collections for clinical reasons e.g. severe anemia, poor venous access, or other.
3.Presence of uncontrolled systemic inflammatory disease
4.Use of oral corticosteroids or use of disease modifying anti-rheumatic drugs

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath